Center for Education

Agenda

Wednesday, June 12, 2013

General Sessions

TAVR Day 1 (8:00 am - 6:00 pm)

Wednesday, June 12
8:00 am - 6:00 pm
Room: Bayshore Grand Ballroom

Session I. TAVR Year in Review

8:00 am - 9:30 am

8:00 am

Welcome and Meeting Overview

8:05 am

The Annual "Mad Dash" Through the Recent TAVR Literature

8:25 am

Discussion with Audience Q&A

8:30 am

Aortic Bioskills 1

Lead Discussant: Mark Reisman

8:45 am

Live Case 1: University Heart Center Hamburg (Hamburg, Germany)

Session II. TAVR Global "Landscape" Perspectives

9:30 am - 12:00 pm

9:30 am

TAVR Penetration and Clinical Outcomes: Observations from EU Experiences and the GARY Registry

9:42 am

Discussion with Audience Q&A

Updates from the US TAVR Commercial Release

9:45 am

Site Training Experiences

9:53 am

Early Insights from the TVT Registry

10:01 am

Discussion

The Heart Team Revisited: Point-Counterpoint

10:05 am

Thriving and Needed More Than Ever

10:13 am

An Artificial Construct Doomed to Extinction

10:21 am

Discussion

TAVR Patient Selection Controversies: Frailty, Futility, and Risk Creep

10:25 am

The Use and Misuse of Risk Scores

10:33 am

How I Select Patients for TAVI in Rouen

10:41 am

Discussion

10:45 am

TAVR Cost-effectiveness and Reimbursement: A Global Gordian Knot

10:57 am

Discussion with Audience Q&A

11:00 am

Aortic Bioskills 2

Lead Discussant: Mark Reisman

11:15 am

Live Case 2: St. Paul's Hospital (Vancouver, Canada)

Session III

12:00 pm - 2:00 pm

Challenging Case Winners 1: Best Cases of the Year

12:00 pm

First-in-human case with a dedicated fully percutaneous TAVR system for pure aortic insufficiency

Case Presenter: Marco Barbanti

12:10 pm

Discussion

12:15 pm

Mitral Valve-in-Valve-in-Valve

Case Presenter: Danny Dvir

12:25 pm

Discussion

12:30 pm

Successful Percutaneous Aortic Valve Closure To Treat Left Ventricular Assist Device - Associated Aortic Insufficiency

Case Presenter: Jean-Michel Paradis

12:40 pm

Discussion

12:45 pm

Melody Valve Implantation into an LV to Ascending Aorta Conduit with Failing Bioprosthesis

Case Presenter: Mario Goessl

12:55 pm

Discussion

1:00 pm

Imaging Skills 1: Echocardiography Essentials for TAVR

1:15 pm

Live Case 3: McGill University Health Centre (Montreal, Canada)

Session IV. TAVR Complications and Vexations

2:00 pm - 4:00 pm

Conduction System Disturbances and Pacemakers

2:00 pm

Incidence and Predictors After TAVR

2:10 pm

Scenario-Based Management Recommendations

2:20 pm

Discussion

 

Annulus Sizing and PVL

2:30 pm

Methods and Guidelines for Optimal TAVR Annulus Sizing

2:40 pm

Perspectives on Post-TAVR Paravalvular Leaks

2:50 pm

Discussion

 

Vascular Complications and Access Alternatives

3:00 pm

Best Clinical Practices for Transfemoral TAVR

3:10 pm

Non-transfemoral Access Alternatives

3:20 pm

Discussion

 

Strokes After TAVR

3:30 pm

Incidence, Timing, and Insights

3:40 pm

Predictors and Contributing Factors

3:50 pm

Discussion

 

Session V. AS Complex Case Management Workshop

4:00 pm - 6:00 pm

Low Flow, Low Gradient AS

4:00 pm

Case Presentation

Case Presenter: Isaac George

4:05 pm

Thoughtful Commentary

Discussant: Philippe Pibarot

4:15 pm

Discussion

 

AS with Simple and Complex CAD

4:20 pm

Case Presentation

Case Presenter: Jean-Michel Paradis

4:25 pm

Thoughtful Commentary

Discussant: James B. Hermiller Jr

4:35 pm

Discussion

 

AS and MR

4:40 pm

Case Presentation

Case Presenter: Ted E. Feldman

4:45 pm

Thoughtful Commentary

Discussant: Marco Barbanti

4:55 pm

Discussion

 

Severe Asymptomatic AS

5:00 pm

Case Presentation

Case Presenter: David A. Wood

5:05 pm

Thoughtful Commentary

Discussant: Patrick T. O'Gara

5:15 pm

Discussion

 

AS with Severe COPD

5:20 pm

Case Presentation

Case Presenter: Danny Dvir

5:25 pm

Thoughtful Commentary

Discussant: Vinod H. Thourani

5:35 pm

Discussion

 

AS with Severe LV Dysfunction

5:40 pm

Case Presentation

Case Presenter: Tamim Nazif

5:45 pm

Thoughtful Commentary

Discussant: Allan Schwartz

5:55 pm

Discussion

 

close | back to top

Workshops

Best of Bioskills I. General Anatomy, Aortic, Mitral (8:30 am - 10:00 am)

Wednesday, June 12
8:30 am - 10:00 am
Room: Seymour Room, Lobby Level

close | back to top

Best of Bioskills II. Mitral: Normal Anatomy and Mitral Valve Pathology (10:30 am - 12:00 pm)

Wednesday, June 12
10:30 am - 12:00 pm
Room: Seymour Room, Lobby Level

close | back to top

Challenging Cases I (10:30 am - 11:45 am)

Wednesday, June 12
10:30 am - 11:45 am
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor

Agenda

10:30 am - 11:45 am

10:30 am

Paravalvular Leak Closure For Persisting Aortic Regurgitation after implantation of the CoreValve Transcatheter Valve

Case Presenter: Petra Poliacikova

10:40 am

Discussion

10:45 am

Transseptal Strategies in Challenging Transcatheter Aortic Valve-in-Valve Implantation

Case Presenter: Simon Cheung Chi Lam

10:55 am

Discussion

11:00 am

An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease

Case Presenter: Peter Pollak

11:10 am

Discussion

11:15 am

A Direct Flow Medical Transcatheter Aortic Valve Implantation Case: Repositioning to Optimize Result and Echo Assessment Prior to Final Implantation

Case Presenter: Federico De Marco

11:25 am

Discussion

11:30 am

Percutaneous Coronary Intervention with Rotablation Atherectomy to Calcified Diffusely Diseased Left Anterior Descending Coronary Artery in a 90 Year Old Patient Through CoreValve Struts

Case Presenter: Mark Aziz

11:40 am

Discussion

close | back to top

Best of Bioskills III. Aortic Valve and Percutaneous Aortic Devices (2:00 pm - 3:30 pm)

Wednesday, June 12
2:00 pm - 3:30 pm
Room: Seymour Room, Lobby Level

close | back to top

How-to Workshop I. Vascular Access and Closure: TF Only (2:00 pm - 3:30 pm)

Wednesday, June 12
2:00 pm - 3:30 pm
Room: Cypress Room 1, 2nd Floor

Agenda

2:00 pm - 3:30 pm

2:00 pm

Vascular Complications: PARTNER Outcomes and Review of the Literature

2:10 pm

Access Screening for TAVR: Who Should and Shouldn't Be Transfemoral Candidates

2:18 pm

Optimal Femoral Access: Variations on How To Do It

Percutaneous Suture-Based Femoral Artery Closure: How Do I Do It? Tips and Tricks

2:26 pm

Columbia University Medical Center (New York, NY)

2:34 pm

Melbourne, Australia

2:42 pm

Vancouver, Canada

2:50 pm

University of Bonn (Bonn, Germany)

2:58 pm

Managing Transfemoral Access Complications: Strategies and Toolbox (Case Examples)

3:08 pm

Are There Indications for Direct Surgical Femoral Artery Cutdown and Repair?

3:16 pm

Discussion with Audience Q&A

close | back to top

New Technology I. Post-TAVR Stroke Issues and Cerebral Protection Devices (2:00 pm - 3:30 pm)

Wednesday, June 12
2:00 pm - 3:30 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor

Stroke Issues

2:00 pm - 2:36 pm

2:00 pm

Taking Strokes Seriously: Definitions (VARC 2), Stroke Grading Scores, Study Endpoints, Neuroimaging, and Neurocognitive Function

2:08 pm

Stroke Frequency and Timing after TAVR: Evolving Insights from the PARTNER Database

2:18 pm

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

2:28 pm

Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen?

Cerebral Protection Devices

2:36 pm - 3:30 pm

2:36 pm

The Embrella Deflector Device: Technology and Early Clinical Experiences

2:44 pm

Status Update of the PROTAVI C Trial in EU

2:52 pm

The Claret Montage Filter Device: Technology and Early Clinical Experiences

3:00 pm

Pathoanatomic Findings from Filtered Debris After TAVR

3:08 pm

The Keystone Deflector Device: Technology and Early Clinical Experiences

3:18 pm

Discussion with Audience Q&A

close | back to top

How-to Workshop II. Patient Selection Controversies for TAVR (eg, Frailty, Futility) (4:00 pm - 5:30 pm)

Wednesday, June 12
4:00 pm - 5:30 pm
Room: Cypress Room 1, 2nd Floor

Risk Scores

4:00 pm - 4:34 pm

4:00 pm

The "Essential Primer" on Surgical Risk Scores: Key Take-home Messages

4:10 pm

Did STS Score or EuroScore Risk Profiles Predict Mortality Outcomes in PARTNER?

4:18 pm

Risk Profiling Schemes Used in the US CoreValve Trial

4:26 pm

How Does the Heart Team Use Risk Scores and Other Parameters to Categorize Patients for TAVR in the European Union?

Frailty

4:34 pm - 5:00 pm

4:34 pm

Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools

4:44 pm

Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial

4:52 pm

Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights

Futility

5:00 pm - 5:16 pm

5:00 pm

Using Quality-of-Life Metrics to Develop a Futility Model in TAVR Patients

5:08 pm

Retrospective Analysis of Poor Outcome Groups from the PARTNER Trial

Intermediate Risk

5:16 pm - 5:30 pm

Should Intermediate-Risk AS Patients (STS Score 4% to 8%) Receive TAVR in 2013?

5:16 pm

Absolutely Not (Rare Exceptions)!

5:23 pm

Many Are Good Candidates Today!

 

close | back to top

New Technology II. New Sheaths, Vascular Closure Devices, Transapical Access Closure Technologies, and Balloon Valvuloplasty Systems (4:00 pm - 5:30 pm)

Wednesday, June 12
4:00 pm - 5:30 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor

Sheaths and Vascular Closure Devices

4:00 pm - 4:36 pm

4:00 pm

New Sheath Technologies for Transfemoral Access: Advantages and Limitations

4:08 pm

The Landscape of Dedicated Transfemoral Closure Devices for TAVR

4:20 pm

Not So Fast! Current Suture-Based Transfemoral Closure Devices Are More Than Adequate: The Vancouver Experience

4:28 pm

Discussion with Audience Q&A

Trans-apical Access-Closure Technologies

4:36 pm - 5:26 pm

4:36 pm

Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure?

4:44 pm

A Whirlwind Tour of the New LV Apical Access Closure Devices: Focus on Technology

4:56 pm

Early Clinical Experiences with the Apica TA-TAVR System

5:04 pm

Early Clinical Experiences with the Entourage TA-TAVR System

5:12 pm

Discussion with Audience Q&A

Balloon Valvuloplasty Systems

5:20 pm - 5:30 pm

5:20 pm

A Review of New Balloon Aortic Valvuloplasty Systems: InterValve Loma Vista, Cardiosculpt, and PiR2

close | back to top

Thursday, June 13, 2013

General Sessions

TAVR Day 2 (8:00 am - 2:00 pm)

Thursday, June 13
8:00 am - 2:00 pm
Room: Bayshore Grand Ballroom

Session VI. New TAVR System

8:00 am - 9:30 am

8:00 am

An Overview of the New and Novel TAVR Systems

8:20 am

Discussion with Audience Q&A

8:30 am

Aortic Bioskills 3

Lead Discussant: Mark Reisman

8:45 am

Live Case 4: University Heart Center Hamburg (Hamburg, Germany)

Session VII. Expanding TAVR Clinical Indications

9:30 am - 10:30 am

Valve-in-Valve for Bioprosthetic Valve Failure

9:30 am

Rationale, Technical Requirements, and Procedural Considerations

9:40 am

Update from the Global Valve-in-Valve TAVR Registry

9:50 am

Discussion

 

Intermediate-Risk AS Patients

10:00 am

TAVR in Intermediate Risk Patients in EU: Reasonable and Appropriate vs. Unwarranted "Risk Creep"

10:08 am

Updates from PARTNER 2A

10:16 am

Updates from SURTAVI

10:24 am

Discussion

 

Session VIII. TAVR Evidence-Based Medicine Corner I

10:30 am - 12:00 pm

10:30 am

VARC 2 Updates and TAVR Clinical Outcomes Using VARC Definitions

10:40 am

Discussion

10:43 am

A Summary of New PARTNER Results from the PARTNER Publications Office (Recent Abstracts and Manuscripts)

10:57 am

Discussion

11:00 am

Aortic Bioskills 4

11:15 am

Live Case 5: McGill University Health Centre (Montreal, Canada)

Session IX

12:00 pm - 2:00 pm

Challenging Case Winners 2: TAVR Complications - Rich Emotional Experiences

12:00 pm

Severe Paravalvular Leak After CoreValve: Percutaneous Closure With Amplatzer Vascular Plugs

Case Presenter: Sameer Gafoor

12:10 pm

Discussion

12:15 pm

Treatment of right coronary artery occlusion after CoreValve implantation

Case Presenter: Corrado Tamburino

12:25 pm

Discussion

12:30 pm

Progressive Transvalvular Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Case Presenter: Fernando Javier Pineda A

12:40 pm

Discussion

12:45 pm

Successful Endovascular Repair of Left Subclavian Rupture After TAVI Implantation

Case Presenter: Daniel Garcia

12:55 pm

Discussion

1:00 pm

Imaging Skills 2: CTA Essentials for TAVR

1:15 pm

Live Case 6: St. Paul's Hospital (Vancouver, Canada)

close | back to top

Mitral Day 1 (2:00 pm - 6:00 pm)

Thursday, June 13
2:00 pm - 6:00 pm
Room: Bayshore Grand Ballroom

Session I. Mitral Valve Therapies Overview

2:00 pm - 3:55 pm

2:00 pm

Mitral Valve Therapies: The Year in Review

2:30 pm

Discussion with Audience Q&A

2:40 pm

Bioskills Presentation: Normal Mitral Valve Anatomy

Discussant: Mark Reisman

2:50 pm

A Primer of Echcardiographic Mitral Valve Assessment: Views, Pathology, and Disease Quantification

3:10 pm

Indications for Surgical and Transcatheter Intervention and in Degenerative and Functional MR: US Guidelines and Perspectives

3:25 pm

Indications for Surgical and Transcatheter Intervention and in Degenerative and Functional MR: EU Guidelines and Perspectives (and Contrasts with the US)

3:40 pm

Discussion with Audience Q&A

Session II. Degenerative MR

3:55 pm - 6:00 pm

3:55 pm

The Spectrum of Surgical Approaches in Degenerative MR: Does Technique, Skill, and Valve Type Matter?

4:10 pm

Early and Late Outcomes After Surgery in Degenerative MR: A Critical Appraisal

4:25 pm

Discussion with Audience Q&A

4:35 pm

Bioskills Presentation: MitraClip Technique and Pathology

Discussant: Mark Reisman

4:45 pm

Taped Case 1: MitraClip in Degenerative MR

Case Presenter: Saibal Kar

5:05 pm

MitraClip Outcomes in Degenerative MR (Low- and High-Risk Surgical Patients): Lessons Learned and Appropriate Patients

5:25 pm

Taped Case 2: MitraClip in Degenerative MR

5:45 pm

Discussion with Audience Q&A

close | back to top

Workshops

MitraClip Technique: An Operator's Guide (8:00 am - 12:00 pm)

Thursday, June 13
8:00 am - 12:00 pm
Room: Stanley Park Ballroom, Salon 3, 2nd Floor

Session I. Case Selection and Echo Imaging

8:00 am - 9:09 am

8:00 am

Step-by-Step Echo Imaging for Evaluation of MR

8:15 am

Quantification of MR

8:30 am

Atrial Septal Puncture for the MitraClip

8:42 am

Mitral Valve Anatomy for the MitraClip: Optimal

8:57 am

Discussion with Audience Q&A

Session II. MitraClip Procedural Steps

9:09 am - 10:20 am

9:09 am

Understanding the MitraClip Device

9:20 am

Optimizing Echo and Fluoro Imaging During the MitraClip Procedure

9:35 am

The MitraClip Procedure Step by Step

9:50 am

Procedural Techniques for Various Mitral Pathologies

10:05 am

Discussion with Audience Q&A

Session III. MitraClip Challenges and Complications

10:20 am - 12:00 pm

10:20 am

Potential Complications of the MitraClip Procedure

10:35 am

My Most Challenging MitraClip Case

Case Presenter: Corrado Tamburino

10:47 am

My Greatest MitraClip Success

10:59 am

My Worst MitraClip Case

Case Presenter: Carlos E. Ruiz

11:11 am

My Worst MitraClip Complication

11:23 am

Surgery Following a Failed MitraClip Procedure: Truth Be Told

11:35 am

Discussion with Audience Q&A

close | back to top

CT Workshop I (8:30 am - 10:00 am)

Thursday, June 13
8:30 am - 10:00 am
Room: Cypress Room 2, 2nd Floor

close | back to top

How-to Workshop III. Vascular Access and Closure: Non-TF Approaches (TA, Direct Ao, and Beyond) (8:30 am - 10:00 am)

Thursday, June 13
8:30 am - 10:00 am
Room: Seymour Room, Lobby Level

Agenda

8:30 am - 10:00 am

8:30 am

Transapical Approach: Advantages, Disadvantages, and How I Do It

8:45 am

Siubclavian Axillary Approach: Advantages, Disadvantages, and How I Do It

9:00 am

Direct Aortic Approach: Advantages, Disadvantages, and How I Do It

9:15 am

Direct Iliac Access: Advantages, Disadvantages, and How I Do It

9:25 am

Transvenous Transeptal Antegrade Approach—A Return to the Past? A Viable Alternative in the "Modern Era"

9:35 am

Carotid Access for TAVR: Are You Kidding?

9:45 am

Discussion: A Sensible Algorithm for Non-TF Access for TAVR

close | back to top

New TAVR Systems I. Edwards Lifesciences and Medtronic (8:30 am - 10:00 am)

Thursday, June 13
8:30 am - 10:00 am
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor

Edwards Lifesciences

8:30 am - 9:15 am

The Sapien 3 TAVR System

8:30 am

Technology Review

8:35 am

Clinical Results

8:40 am

Case Examples

 

The Centera Self-Expanding TAVR System

8:50 am

Technology Review

8:55 am

Clinical Results

9:00 am

Case Examples

Case Presenter: Eberhard Grube

 

The Helio Docking TAVR System for Aortic Insufficiency

9:05 am

Technology Review

9:08 am

Clinical Results

9:11 am

Case Examples

 

Medtronic

9:15 am - 10:00 am

The CoreValve Evolut TAVR System

9:15 am

Technology Review

9:20 am

Clinical Results

9:25 am

Case Examples

 

The Engager TA-TAVR System

9:35 am

Technology Review

9:40 am

Clinical Results

9:45 am

Case Examples

 

New Accessories (In-line Sheath/Catheter and Dedicated Guidewires)

9:55 am

Technology Review

 

close | back to top

Challenging Cases II (10:30 am - 12:00 pm)

Thursday, June 13
10:30 am - 12:00 pm
Room: Oak Room, 2nd Floor

Agenda

10:30 am - 12:00 pm

10:30 am

Combined transapical and transfemoral approaches for challenging simultaneous mitro-aortic paravalvular leak closure

Case Presenter: Francesco Maisano

10:40 am

Discussion

10:45 am

Antegrade Transcatheter Aortic Valve Replacement Utilizing Femoral Venous and Bilateral Upper Extremity Arterial Access

Case Presenter: Justin P Levisay

10:55 am

Discussion

11:00 am

Mitral Valve Replacement With The Sapien™ XT On Fibrillating Heart (In Previously Implanted Aortic Corevalve®)

Case Presenter: Enrico Ferrari

11:10 am

Discussion

11:15 am

Novel Sliding Balloon Technique in TAVR in patients with Horizontal Porcelain Aortas

Case Presenter: Puvi Seshiah

11:25 am

Discussion

11:30 am

Transfemoral TAVR in a patient with Bioprosthetic Mitral valve and LV dysfunction

Case Presenter: Puvi Seshiah

11:40 am

Discussion

11:45 am

Cardiogenic Shock due to Severe Ischemic Mitral Regurgitation: MitraClip Therapy as a Bridge to Surgical Intervention

Case Presenter: Anita Asgar

11:55 am

Discussion

close | back to top

How-to Workshop IV. Valve Sizing and Management of Intraprocedural PVL (10:30 am - 12:45 pm)

Thursday, June 13
10:30 am - 12:45 pm
Room: Seymour Room, Lobby Level

Valve Sizing

10:30 am - 11:43 am

10:30 am

Use of the "Cover Index" for Valve Sizing to Predict PVL After TAVR

10:38 am

A Prospective Multicenter Evaluation of CT Sizing for TAVR

10:46 am

CT Sizing Algorithms for Balloon-Expandable Valves: Methodology, Guidelines, and Helpful Tips

10:54 am

CT Sizing Algorithms for Self-Expanding Valves: The US CoreValve Experience

11:02 am

Balloon Sizing Facilitates Valve Selection for TAVR

11:10 am

Balloon Undersizing as Part of a CT Sizing Strategy: CT Assessment of THV Expansion and Correlation with PVL

11:18 am

The Use and Value of 3-D TEE During TAVR for (1) Valve Sizing and (2) THV Positioning

11:30 am

Comparison of CT and 3-D TEE for THV Sizing and Prevention of PVL

11:38 am

Discussion with Audience Q&A

Intra-procedure PVL

11:43 am - 12:42 pm

11:43 am

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR: A Recent Meta-Analysis

11:53 am

Hemodynamic Assessment of PVL after TAVR: Using the AR Index to Define Severity and Guide Therapy

12:03 pm

Echo Assessment of PVL After TAVR: Definitions and Guidelines for Treatment

Post-Dilatation to Reduce PVL After TAVR

12:13 pm

The French Experience

12:21 pm

Concerns from Canada

12:29 pm

The US-Columbia Strategy

12:37 pm

Discussion with Audience Q&A

close | back to top

New TAVR Systems II. Symetis, Direct Flow Medical, and JenaValve (10:30 am - 12:00 pm)

Thursday, June 13
10:30 am - 12:00 pm
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor

Symetis: ACURATE TA and ACURATE TF

10:30 am - 11:00 am

Technology and Clinical Results

10:30 am

ACURATE Transapical

10:40 am

ACURATE Transfemoral

10:50 am

Case Examples

 

Direct Flow Medical: TF

11:00 am - 11:30 am

11:00 am

Technology Review

11:10 am

Clinical Results: The Discover Trial

11:20 am

Case Examples

JenaValve: TA

11:30 am - 12:00 pm

11:30 am

Technology Review

11:40 am

Clinical Results – The Jupiter Registry and AR Results

11:50 am

Case Examples

close | back to top

Special Session I. Health Economics and Reimbursement: Global Perspectives (10:30 am - 12:05 pm)

Thursday, June 13
10:30 am - 12:05 pm
Room: Cypress Room 1, 2nd Floor

Health Economics and Reimbursement: Global Perspectives

10:30 am - 12:03 pm

10:30 am

Can We Afford TAVR? Impact on US Hospitals and Health Systems: Lessons from PARTNER and Beyond

10:45 am

Cost-effectiveness of Surgical AVR vs. TAVR Using Registry Data

10:55 am

The Impact of Reimbursement on TAVR Utilization in Europe

Economic Consequences of TAVR in US Hospitals: Case Examples

11:05 am

Dallas, TX

11:13 am

Atlanta, GA

11:21 am

A Primer on Billing and Reimbursement in the United States: Tips, Pitfalls, and Realities

11:31 am

Why Does TAVR Cost So Much? Perspectives from the Medical Device Industry

11:41 am

Novel Reimbursement Models and the Impact on New Technology

11:53 am

Discussion with Audience Q&A

close | back to top

CT Workshop II (2:00 pm - 3:30 pm)

Thursday, June 13
2:00 pm - 3:30 pm
Room: Cypress Room 2, 2nd Floor

close | back to top

Echo Workshop I (2:00 pm - 3:30 pm)

Thursday, June 13
2:00 pm - 3:30 pm
Room: Mackenzie Room, Lobby Level

close | back to top

How-to Workshop V. Percutaneous Closure of Paravalvular Leaks (2:00 pm - 3:30 pm)

Thursday, June 13
2:00 pm - 3:30 pm
Room: Seymour Room, Lobby Level

Agenda

2:00 pm - 3:30 pm

2:00 pm

A Comprehensive Overview of Paravalvular Leak Closure: Techniques, and Clinical Outcomes

2:15 pm

Step-by-Step Approach to Aortic Paravalvular Leak Closure (Including Case Presentations

2:30 pm

Transseptal Closure of Mitral Paravalvular Leaks (Including Case Presentations)

2:40 pm

Percutaneous Apical Closure of Mitral Paravalvular Leaks (Including Case Presentations)

2:50 pm

Transthoracic Apical Closure of Mitral Paravalvular Leaks, with TEE guidance (Including Case Presentations)

3:00 pm

Paravalvular Leak Closure After TAVR: Indications and Technical Insights

3:10 pm

Discussion with Audience Q&A

close | back to top

New TAVR Systems III. Sadra Medical, St. Jude Medical, Others (2:00 pm - 3:40 pm)

Thursday, June 13
2:00 pm - 3:40 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor

St. Jude's Portico: TF and TA

2:00 pm - 2:30 pm

2:00 pm

Technical Review

2:10 pm

Clinical Results

2:20 pm

Case Examples

Sadra Medical: TF

2:30 pm - 3:00 pm

2:30 pm

Technical Review

2:40 pm

Clinical Results from Reprise I and II

2:50 pm

Case Examples

Others

3:00 pm - 3:40 pm

3:00 pm

The Colibri TAVR System

3:08 pm

The Inovare TAVR System (Braile Biomedical, Brazil)

3:16 pm

The Venus TAVR System (Venus MedTec, China)

3:24 pm

The Valve Medical TAVR System (Israel)

3:30 pm

The Thubikar TAVR system

3:36 pm

Discussion

close | back to top

How-to Workshop VI. Procedural Considerations (eg, Balloon Valvuloplasty, Anesthesia Monitoring, New Pacemakers) and Important (but Often Less Common) TAVR Complications (4:00 pm - 6:00 pm)

Thursday, June 13
4:00 pm - 6:00 pm
Room: Seymour Room, Lobby Level

Procedural Considerations

4:00 pm - 4:57 pm

4:00 pm

TAVR "Redux:" Cath Lab Setting, Necessary Staffing, No General Anesthesia, TTE and Surgery as Needed, and Early Discharge

4:10 pm

TAVR "Extraordinaire:" My Compelling Case to Preserve TEE as Fundamental to TAVR

4:18 pm

Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure

4:28 pm

Direct TAVR Without Predilatation: Rationale and Results

4:36 pm

Interpretation, Frequency, and Management Strategy of Conduction Abnormalities During TAVR

4:46 pm

The 3M Approach to TAVR Permits Safe Next Day Discharge in High Risk Patients

4:52 pm

Discussion with Audience Q&A

Important TAVR Complications

4:57 pm - 6:00 pm

4:57 pm

Predicting Complications after TAVR: Are we there Yet?

5:05 pm

Bleeding Complications After TAVR (and SAVR): An Often Misunderstood and Neglected Complication

5:15 pm

Coronary Occlusion After TAVR: Review of a Multicenter Experience

5:25 pm

A Mulitcenter Evaluation of Annulus Rupture After TAVR: Preprocedural CT Risk Factors

5:35 pm

Case Series of Valve Thrombus After TAVR: Clinical Recognition and Management

5:43 pm

Interesting Echo Complications After TAVR: VSDs and Peri-aortic Hematomas

5:53 pm

Discussion with Audience Q&A

close | back to top

New Technology III. Hybrid Cath Lab/OR and Advanced Imaging Systems (4:00 pm - 5:30 pm)

Thursday, June 13
4:00 pm - 5:30 pm
Room: Stanley Park Ballroom, Salon 1-3, 2nd Floor

Hybrid Cath Lab/OR

4:00 pm - 4:30 pm

4:00 pm

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

4:15 pm

A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences

4:25 pm

Discussion with Audience Q&A

Advanced Imaging

4:30 pm - 5:30 pm

4:30 pm

The Optimal Imaging Environment for TAVR Procedures: General Considerations and Alternatives

4:38 pm

The Philips Heart Navigator System and Fluoroscopic Coregistration

4:46 pm

The GE Innova Vision System

4:54 pm

The Siemens Dyna-CT System

5:02 pm

The Paieon Angiographic Analysis and Positioning System: Utility and Analytical Observations

5:12 pm

New Intraprocedural Echo Systems for TAVR: 3-D, ICE, Micro, and New Software

5:22 pm

Discussion with Audience Q&A

close | back to top

Friday, June 14, 2013

General Sessions

TAVR Day 3 (8:00 am - 2:00 pm)

Friday, June 14
8:00 am - 2:00 pm
Room: Bayshore Grand Ballroom

Session X. New TAVR Accessory Devices

8:00 am - 9:30 am

8:00 am

Cerebral Embolic Protection Devices

8:12 am

Discussion with Audience Q&A

8:15 am

New Access and Closure Devices: Vascular and LV Apical

8:21 am

New Access and Closure Devices: Vascular and LV Apical

8:27 am

Discussion with Audience Q&A

8:30 am

Aortic Bioskills 5

Lead Discussant: Mark Reisman

8:45 am

Live Case 7: St. Paul's Hospital (Vancouver, Canada)

Session XI. TAVR Procedural Considerations

9:30 am - 10:30 am

9:30 am

Pre- and Post-Dilatation Considerations: Strategic Decision Making

9:40 am

Discussion with Audience Q&A

9:45 am

"Minimalist" Approach: No General Anesthesia, Transthoracic Echo and Surgeons, "As Needed"

9:55 am

Discussion with Audience Q&A

10:00 am

Pearls on Vascular Access Choices

10:10 am

Discussion with Audience Q&A

10:15 am

The Case for the Hybrid OR-Cath Lab

10:25 am

Discussion with Audience Q&A

Session XII. TAVR Evidence-Based Medicine Corner II

10:30 am - 12:00 pm

10:30 am

Featured Lecture: Baseline Patient Characteristics from the US CoreValve Clinical Trial

10:45 am

Discussion with Audience Q&A

10:50 am

Updates from the Edwards SOURCE Registries

11:00 am

Updates from the ADVANCE CoreValve Registry

Key Vignettes from the TAVR Country Registries

11:10 am

United Kingdom

11:20 am

11:30 am

11:40 am

11:50 am

Discussion: The Value of TAVR Registries

Session XIII.

12:00 pm - 2:00 pm

Challenging Case Winners 3: Mitral/LAA Case Adventures

12:00 pm

Transcatheter Closure of Incomplete Left Atrial Appendage Occlsuion (Previous Watchman LAA Occluder) - Implantation of a 2nd Generation ACP (Amulet) Device

Case Presenter: Simon Cheung Chi Lam

12:10 pm

Discussion

12:15 pm

Case Report from Bonn Germany with the Mitralign Annuloplasty System

Case Presenter: Georg Nickenig

12:25 pm

Discussion

12:30 pm

EchoNavigator for MitraClip: Use of A New Real-time Echo-Fluoro Overlay technology

Case Presenter: Sameer Gafoor

12:40 pm

Discussion

12:45 pm

First-in-man Simultaneous Left Atrial Appendage Ligation with Transapical TAVR

Case Presenter: Puvi Seshiah

12:55 pm

Discussion

1:00 pm

Mitraclip Bioskills 6

Lead Discussant: Mark Reisman

1:15 pm

Thoughtful Mitralclip Discussion

close | back to top

Mitral Day 2 (2:00 pm - 6:00 pm)

Friday, June 14
2:00 pm - 6:00 pm
Room: Bayshore Grand Ballroom

Section III. Functional MR

2:00 pm - 5:00 pm

2:00 pm

Bioskills Presentation: Pathology of Functional MR

Discussant: Mark Reisman

2:10 pm

Impact of Function MR on Outcomes in Ischemic and Idiopathic Dilated Cardiomyopathy: Major Culprit or Innocent Bystander?

2:25 pm

Surgery in Functional MR: Glass Half Full Perspectives

2:40 pm

Surgery in Functional MR: Glass Half Empty Perspectives

2:55 pm

Discussion with Audience Q&A

3:10 pm

Live Case 1: MitraClip in Functional MR, St. Paul's Hospital (Vancouver, Canada)

3:55 pm

MitraClip Outcomes in Functional in Functional MR (Low- and High-Risk Surgical Patients): Lessons Learned and Appropriate Patients

4:15 pm

MitraClip Technique Primer: Minimizing Residual MR, Complications and the Learning Curve

4:30 pm

Randomized Trials of the MitraClip in FMR: From COAPT to RESHAPE

4:45 pm

Discussion with Audience Q&A

Session IV. Emerging Transcatheter Mitral Valve Therapies

5:00 pm - 6:00 pm

5:00 pm

Bioskills Presentation 2: Beyond the MitraClip

Discussant: Mark Reisman

5:15 pm

Progress with Transcatheter Mitral Valve Therapies (non-MitraClip, non-PerQ Valves)

5:35 pm

Rationale for and Progress with Percutaneous Mitral Valve Implants

5:45 pm

Discussion with Audience Q&A

close | back to top

Workshops

Novel Transcatheter Mitral Valve Therapies (8:00 am - 11:45 am)

Friday, June 14
8:00 am - 11:45 am
Room: Stanley Park Ballroom, Salon 3, 2nd Floor

Session I. The Principal Mitral TVT Contenders

8:00 am - 10:12 am

8:00 am

Does Transcatheter Valve Therapy Need to Eliminate MR to Be Successful?

8:12 am

The History of Coronary Sinus Approaches: One Left Standing

8:27 am

Carillon Case (wtih Long-term Follow-up)

8:37 am

Discussion with Audience Q&A

8:47 am

Transatrial Annuloplasty: The Valtech Cardioband

9:02 am

Progress with the Mitralign Percutaneous Annuloplasty System: EU and US Studies

9:17 am

Basal Ventriculoplasty: Guided Delivery Systems' Accucinch

9:32 am

Discussion with Audience Q&A

9:42 am

Can the Coronary Sinus Approach or Annuloplasty "Work" in FMR? A Surgical Perspective

9:57 am

Combination TVT Techniques: MitraClip Plus

Session II. Alternative Mitral Valve TVT Approaches

10:12 am - 11:45 am

10:12 am

The Promise and Reality of Surgical and Transcatheter Implantable Cords

10:27 am

Progress with the CardoSolutions Mitra-Spacer

10:42 am

Are Adjustable Valves (Surgical and Percutaneous) an Important Advance?

10:57 am

Description and Results of Valve-in-Valve for Degenerated Mitral Protheses

11:12 am

Transcatheter Mitral Valve Replacement: Rationale, Hurdles, and Devices

11:27 am

Panel Discussion with Audience Q&A

close | back to top

CT Workshop III (8:30 am - 10:00 am)

Friday, June 14
8:30 am - 10:00 am
Room: Cypress Room, 2nd Floor

close | back to top

Special Session II. Valve-in-Valve Workshop for Bioprosthetic Valve (or Ring) Failure (8:30 am - 10:52 am)

Friday, June 14
8:30 am - 10:52 am
Room: Seymour Room, Lobby Level

Valve-in-Valve Workshop for Bioprosthetic Valve (or Ring) Failure

8:30 am - 10:52 am

8:30 am

Results and Lessons from the Global TAVR Valve-in-Valve Registry

Aortic Valve-in-Valve

8:42 am

Technology Considerations: Understanding the Anatomy of Aortic Bioprosthetic Surgical Valves

8:52 am

Procedural Tips and Clinical Outcomes using the Balloon-Expandable THV (Edwards): Taped Case from Vancouver

9:07 am

Procedural Tips and Clinical Outcomes using the Self-Expandable THV (CoreValve): Case Examples

9:19 am

Discussion with Audience Q&A

Mitral Valve-in-Valve and Rings

9:29 am

Mitral Valve-in-Valve (or Rings): How I Do the Transseptal Approach (Case Examples)

9:39 am

Technology Considerations: Understanding the Anatomy of Mitral Bioprosthetic Surgical Valves and Mitral/Tricuspid Rings

9:54 am

Procedural Tips and Clinical Outcomes using the Balloon-Expandable THV (Edwards): Taped Case from Vancouver

10:02 am

Mitral Valve-in-Valve (or Rings): How I Do the Transapical Approach

Case Presenter: Isaac George

10:10 am

Mitral Valve-in-Valve (or Rings): How I Do the Transseptal, Transapical Approach (Case Examples)

10:18 am

The Trans-apical Aortic and Mitral Valve-in-Valve (or ring) (Case Examples)

10:26 am

Mitral and Tricuspid Valve-in-Rings from the Global Registry

10:34 am

Tricuspid Valve-in-Valve (or ring): Techniques and Case Examples

10:42 am

Discussion with Audience Q&A

close | back to top

Challenging Cases III (10:30 am - 11:45 am)

Friday, June 14
10:30 am - 11:45 am
Room: Cypress Room, 2nd Floor

Agenda

10:30 am - 12:00 pm

10:30 am

Acute RCA occlusion secondary to valve in valve deployment

Case Presenter: Vijay S Iyer

10:40 am

Discussion

10:45 am

Real-time Monitoring of an Intra-procedural Thrombus During Delivery of an Edwards SAPIEN Transcatheter Heart Valve

Case Presenter: Emil Missov

10:55 am

Discussion

11:00 am

When Size Does Matter: The First Case Of A TAVR Device Resheathing and Size Change

Case Presenter: Ian T. Meredith

11:10 am

Discussion

11:15 am

Transcatheter Aortic Valve implantation As Bridge to Heart Transplantation

Case Presenter: Giuseppe Bruschi

11:25 am

Discussion

11:30 am

Severe bicuspid aortic valve stenosis and very large aortic annulus treated with supraannular implantation of 31mm Medtronic CoreValve

Case Presenter: Wojciech Wojakowski

11:40 am

Discussion

close | back to top

CT Workshop IV (10:30 am - 12:00 pm)

Friday, June 14
10:30 am - 12:00 pm
Room: Cypress Room 2, 2nd Floor

close | back to top

Echo Workshop II (2:00 pm - 3:30 pm)

Friday, June 14
2:00 pm - 3:30 pm
Room: Mackenzie Room, Lobby Level

close | back to top

Heart Team I. Best Practices for TAVR Program Clinical Operations (2:00 pm - 3:30 pm)

Friday, June 14
2:00 pm - 3:30 pm
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor

Agenda

2:00 pm - 3:30 pm

2:00 pm

The Role of the TAVR Coordinator: Essential to Sustained Program Success

2:10 pm

Supporting Case Selection: From Referral, Through Screening and Evaluation

2:20 pm

We can do it, but should we do it? Quantifying Frailty and Futility

2:30 pm

Meeting Education Needs: Patients, Families and interdisciplinary Teams

2:40 pm

The Heart Valve Clinic: A Central Component of Clinical Decision-Making

2:50 pm

Organizing the Heart Valve Clinical In-hospital Service: Practical Tips and Lessons

3:00 pm

Optimizing Post-procedure Care to Minimize Length of Stay

3:10 pm

Organizing the Cath Lab Heart Team: Establishing a Checklist Sequence

3:20 pm

close | back to top

Special Session III. Canadian Association of Interventional Cardiology Workshop (2:00 pm - 3:30 pm)

Friday, June 14
2:00 pm - 3:30 pm
Room: Seymour Room, Lobby Level

Canadian Association of Interventional Cardiology

2:00 pm - 3:30 pm

2:00 pm

Introduction

2:05 pm

TAVI Future Adaptations and Applications

2:23 pm

Patient selection for MitraClip: Who Benefits?

2:41 pm

Optimal vs. Essential Pre-TAVR Imaging: Peripheral Angio, Echo, and CT

2:59 pm

A Minimalist, Multidisciplinary, and Multimodality Approach to TAVR: Facilitating Early Discharge

3:15 pm

Discussion with Audience Q&A

close | back to top

Heart Team II. Challenges for TAVR Program Growth (4:00 pm - 5:30 pm)

Friday, June 14
4:00 pm - 5:30 pm
Room: Stanley Park Ballroom, Salon 1-2, 2nd Floor

Agenda

4:00 pm - 5:30 pm

4:00 pm

Unique Challenges of Supporting TAVR Clinical Trials

4:10 pm

Careful Case Triaging for Next Day Discharge Following TAVR

4:20 pm

Alternative Access for TAVR: Emerging Best Practices and Clinical Support Requirements

4:30 pm

The Right Care for the Right Person: Integrating a Palliative Approach in TAVR Programs

4:40 pm

A Primer on Billing and Reimbursement after TAVR

4:50 pm

What a Geriatrician can do for TAVR Patients and Programs

5:00 pm

Experiences from a “Start-up” TAVR Center: Challenges and Rewards

5:10 pm

close | back to top

Saturday, June 15, 2013

General Sessions

Left Atrial Appendage (LAA) Session (8:00 am - 3:40 pm)

Saturday, June 15
8:00 am - 3:40 pm
Room: Bayshore Grand Ballroom

Session I. LAA Anatomy and Imaging

8:00 am - 8:40 am

8:00 am

Relational Aspects of LAA Anatomy

8:10 am

Basic Echo Imaging of the LAA with Fluoroscopic Correlation

8:20 am

CT Imaging of the LAA: Necessary for All or Device Specific?

8:30 am

Discussion with Audience Q&A

Session II. Setting the Stage

8:40 am - 10:20 am

8:40 am

Defining Nonvalvular A-fib: Not So Simple

8:50 am

Surgical Methods and Outcomes for LAA Closure

9:00 am

"New" Anticoagulation Options for A-fib: Beyond Warfarin

9:15 am

EP Perspective: Where Will A-fib Ablation Take Us in the Next Five Years?

9:25 am

Review of Risk Scores and How They Guide Therapy

9:35 am

Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?

9:45 am

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

9:55 am

Management of the Patient with Chronic LAA Thrombus and/or Spontaneous Echo Contrast with Closure Devices

10:05 am

Discussion with Audience Q&A

Session III. Imaging the LAA: Procedural Guidelines

10:20 am - 11:00 am

10:20 am

Understanding LAA Anatomy for Optimal Device Selection

10:30 am

TEE Imaging for LAA Closure

10:40 am

Integrating TEE and Fluoroscopy for LAA Therapies

10:50 am

Discussion with Audience Q&A

Session IV. Techniques and Devices for LAA Occlusion

11:00 am - 12:30 pm

11:00 am

Optimal Transseptal Technique for LAA Occlusion

11:10 am

Optimal Technique for Pericardial Access

11:20 am

Current and (Near) Future Devices: Does Design Dictate Choice?

11:35 am

Case Presentation: Amplatzer Cardiac Plug (St. Jude Medical)

Case Presenter: Jacqueline Saw

11:45 am

Case Presentation: Watchman (Boston Scientific)

Case Presenter: Mark Reisman

11:55 am

Case Presentaton: Lariat (SentreHEART)

Case Presenter: Matthew J. Price

12:05 pm

Case Presentation: Wavecrest (Coherex Medical)

Case Presenter: Brian K. Whisenant

12:15 pm

Discussion with Audience Q&A

Session V. Watchman Clinical Program

12:30 pm - 1:20 pm

12:30 pm

The Watchman Device: Form vs. Function

12:40 pm

Keynote Address: Interpreting PROTECT AF, CAP, and PREVAIL: Who Is the Ideal Patient?

12:55 pm

How to Avoid Complications with the Watchman Device

1:05 pm

Discussion with Audience Q&A

Session VI. Future Evolution and Challenges of LAA Closure

1:20 pm - 2:25 pm

1:20 pm

LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense

1:30 pm

Sentreheart: A Leap from Ligation to Stroke Reduction: Treatment Recommendations in the Absence of a Trial

1:40 pm

Residual Leaks and Thrombus Formation

1:50 pm

Emerging Therapies for LAA Occlusion: The New Devices

2:00 pm

Mixed Marriage: TAVR and LAA Occlusion

2:10 pm

Discussion with Audience Q&A

Session VII. Provocative and Challenging Cases

2:25 pm - 3:25 pm

2:25 pm

Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology

Case Presenter: Steven J. Yakubov

2:32 pm

Case Discussion

2:40 pm

Complication of LAA Closure: Lariat (SentreHEART)

Case Presenter: Matthew J. Price

2:47 pm

Case Discussion

2:55 pm

Complication of LAA Closure: Watchman (Boston Scientific)

Case Presenter: Mark Reisman

3:02 pm

Case Discussion

3:10 pm

Postprocedure Thrombus

Case Presenter: Ted E. Feldman

3:17 pm

Case Discussion

close | back to top